Total planned funding: $411,621,887
Clear active filters
FHI 360
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Nigeria | $112,695,424 |
Mozambique | $63,802,475 |
Zambia | $42,277,435 |
Kenya | $25,501,776 |
South Africa | $23,992,984 |
Vietnam | $20,807,722 |
Burundi | $13,325,539 |
Ethiopia | $12,279,178 |
Tanzania | $10,668,020 |
Haiti | $10,548,100 |
Zimbabwe | $8,990,190 |
Côte d'Ivoire | $8,596,690 |
Democratic Republic of the Congo | $8,359,731 |
Botswana | $8,103,106 |
Ghana | $6,982,500 |
Uganda | $4,715,352 |
India | $4,650,000 |
Malawi | $4,372,663 |
Rwanda | $4,308,060 |
Papua New Guinea | $3,494,885 |
South Sudan | $2,868,967 |
Eswatini | $2,650,187 |
Indonesia | $2,330,000 |
Angola | $2,250,000 |
Namibia | $1,947,275 |
Lesotho | $903,628 |
Dominican Republic | $200,000 |
Caribbean Region | $0 |
Cambodia | $0 |
Organizational Types
NGO | $411,621,887 |
Program Areas
Care | $146,688,703 |
Treatment | $99,252,179 |
Prevention | $96,529,088 |
Governance and Systems | $39,267,650 |
Testing | $29,884,267 |
Budget Codes
HTXS: Treatment: Adult Treatment | $88,608,007 |
HKID: Care: Orphans and Vulnerable Children | $75,724,515 |
HVOP: Sexual Prevention: Other Sexual Prevention | $50,579,085 |
HBHC: Care: Adult Care and Support | $50,556,541 |
HVCT: Testing: HIV Testing and Counseling | $29,884,267 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $29,263,998 |
HLAB: Laboratory Infrastructure | $17,925,226 |
OHSS: Health Systems Strengthening | $11,499,898 |
HVTB: Care: TB/HIV | $11,353,442 |
PDTX: Treatment: Pediatric Treatment | $10,644,172 |
HVSI: Strategic Information | $9,842,526 |
PDCS: Care: Pediatric Care and Support | $9,054,205 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $8,199,862 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $4,400,599 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $3,394,875 |
HMIN: Biomedical Prevention: Injection Safety | $487,834 |
HMBL: Biomedical Prevention: Blood Safety | $202,835 |
HTXD: Treatment: ARV Drugs | $0 |
Top Partner Programs
FHI 360:
$411,621,887
View countries